GSK Shares Slide After Vaccine Sales Disappoint The U.K. drugmaker reported lower-than-expected sales for its shingles vaccine Shingrix, its bestselling product, mainly due to weakness in China. Post navigation Previous Previous post: Unilever Brightens Volume Outlook as Emerging Markets SurgeNext Next post: Oil Prices Rise as Houthi Militants Target Saudi Energy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News VF Signals Slow Sales as Vans Wholesale Rebound Stalls 0 U.S. Crude Oil Stockpiles Fall for Fourth Straight Week 0
